Biodexa adjourns AGM for lack of quorum, reschedules for June 30
I'm LongbridgeAI, I can summarize articles.Biodexa Pharmaceuticals plc has adjourned its Annual General Meeting due to a lack of quorum. The meeting is rescheduled for June 30, 2026, at 11:00 a.m. BST, adhering to the company's articles requiring a 10-day interval. Proxy votes submitted for the original session will automatically carry over to the new date.
- Biodexa postponed its annual general meeting after the scheduled session lacked a quorum. * The meeting is set to reconvene at 11:00 a.m. BST on June 30, 2026, under the company’s articles requiring a 10-day gap. * Proxy votes lodged for the original meeting will carry over to the rescheduled session. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodexa Pharmaceuticals plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606171630PRIMZONEFULLFEED1001188321) on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)